Document Detail


Effect of heat-drug sequences on thermoenhancement and uptake of cis-DDP in human pharyngeal carcinoma.
MedLine Citation:
PMID:  8615624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To discover the point of maximum interactive effect, we examined the time sequence of high (above (42.5 degrees C) or low (below 42.5 degrees C) -hyperthermia and cis-diammine dichloroplatinum (II) (CDDP). Simultaneous or post-hyperthermic CDDP (0.5 micrograms/ml) treatment at 43 degrees C resulted in a slight synergistic effect, with thermoenhancement ratios (TER) of 1.42 or 1.38, respectively, and there was a significant increase CDDP uptake after both combinations compared with pre-hyperthermic CDDP treatment. However, at 42 degrees C, the maximal interaction (TER = 8.57) was obtained when KB cells were simultaneously heated with CDDP, there was also a significant increase of CDDP uptake by simultaneous procedures compared with pre or post-hyperthermic CDDP treatment. These results indicate that simultaneous or post-hyperthermic CDDP treatment for high-hyperthermia and simultaneous CDDP treatment for low-hyperthermia are the most effective means of CDDP thermochemotherapy with hyperthermia.
Authors:
T Ohtsubo; H Saito; N Tanaka; I Noda; T Saito; E Kano
Related Documents :
22738974 - Comprehensive analysis of flavonols in ginkgo biloba products by ultra-high-performance...
22806724 - Interaction of lactic acid bacteria with metal ions: opportunities for improving food s...
20652644 - Content variations of the tomato saponin esculeoside a in various processed tomatoes.
7871354 - Effect of buccal administration of a lactose-containing nitroglycerin tablet (suscard) ...
21074594 - Risk assessment of streptomycin and tetracycline residues in meat and milk on croatian ...
21513194 - Quality and digestibility of food ingested by various trophic fish groups in the upper ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  16     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1996 Jan-Feb
Date Detail:
Created Date:  1996-06-05     Completed Date:  1996-06-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  297-300     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology, Fukui Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacokinetics,  pharmacology*
Cell Death / drug effects,  physiology
Cisplatin / pharmacokinetics,  pharmacology*
Combined Modality Therapy
Humans
Hyperthermia, Induced*
KB Cells
Temperature
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisom...
Next Document:  Enhancement of antitumor effects of new analogue of platinum, cis-diammine (glycolato) platinum (254...